Lunch-N-Learn: Exploring Sodium Channel Inhibition for the Management of Acute Pain

Moderator(s)

• JM

  Jai Mehta, MD, MBA, FASA

  Senior Medical Director, Pain
  Vertex Pharmaceuticals Incorporated

Please join us in this session to learn more about the role of suzetrigine, a nonopioid pain signal inhibitor, in the management of moderate-to-severe acute pain. In this session we will explore the role of NaV1.8 in pain signaling, suzetrigine’s mechanism of action, and findings from our clinical studies evaluating suzetrigine. We will then gain clinical insights on the incorporation of its use in practice through discussions on
real-world experience with suzetrigine.

Presenter:
Jai Mehta, MD, MBA, FASA
Senior Medical Director, Pain
Vertex Pharmaceuticals Incorporated
Boston, MA

Sponsored by: Vertex